Gene silencing approaches for the treatment of hepatitis C virus infection

Genetic variability of NS5B region of Hepatitis C Virus patients in Egypt

Characterization of Drug –resistance Profiles to Directly Acting Agents in Hepatitis C virus Naive Patients

The relation between interleukin 28B gene polymorphisms (rs8099917 and rs12980275) and the response of treatment of Hepatitis C Virus genotype 4 patients to Sofosbuvir and Daclat

Genetic Polymorphism in the Human IL-10 and Human IL-28 B with Increased Risk of Hepatitis B Virus Infection

MOLECULAR MARKERS PREDICTING THE EFFICACY OF INTERFERON-BASED THERAPIES IN PATIENTS WITH CHRONIC HEPATITIS C

Recent trends in chronic hepatitis C virus treatment

Genetic Variability of NS5B Region of Hepatitis C Virus in Togo

Quantitative and Qualitative Evaluation of Hepatitis C Virus Core Antigen (HCVcAg) as an Alternative Diagnostic Marker in Chronic HCV Infection

Predictors of Sustained Virological Response in Chronic Hepatitis C Patients Treated with Current Direct Acting Antiviral Drugs